Detailed stratified GWAS analysis for severe COVID-19 in four European populations

Abstract
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our understanding of underlying disease mechanisms. Here, we describe an extended genome-wide association meta-analysis of a well-characterized cohort of 3255 COVID-19 patients with respiratory failure and 12 488 population controls from Italy, Spain, Norway and Germany/Austria, including stratified analyses based on age, sex and disease severity, as well as targeted analyses of chromosome Y haplotypes, the human leukocyte antigen region and the SARS-CoV-2 peptidome. By inversion imputation, we traced a reported association at 17q21.31 to a ~0.9-Mb inversion polymorphism that creates two highly differentiated haplotypes and characterized the potential effects of the inversion in detail. Our data, together with the 5th release of summary statistics from the COVID-19 Host Genetics Initiative including non-Caucasian individuals, also identified a new locus at 19q13.33, including NAPSA, a gene which is expressed primarily in alveolar cells responsible for gas exchange in the lung.
Funding Information
  • Deutsche Forschungsgemeinschaft (SCHU 2419/2-1, RA 1971/6-1, LU-1944/3-1)
  • Juan de la Cierva Incorporacion program (IJC2018-035131-I)
  • German Federal Ministry of Education and Research (01ED1619A)
  • Research Council of Norway (312769, 312780)
  • Spanish Ministry of Economy, Innovation and Competition, the Instituto de Salud Carlos III (GLD19/00100, PI17/00535, PI19/00589, PI16/01842, PI19/01404)
  • Agencia Estatal de Investigación (AEI, Spain) and the European Regional Development Fund (PID2019-107836RB-I00, BFU2016-77244-R)
  • Basque Foundation for Health Innovation and Research-BIOEF
  • Acción Estratégica en Salud (ISCIII) and the FEDER
  • Spanish Ministry of Economy and Competitiveness (IPT-010000-2010-36, PSE-010000-2006-6)
  • European Regional Development Fund
  • VEIS project (001-P-001647)
  • Agència de Gestió d’Ajuts Universitaris i de Recerca (2017-SGR 529)
  • Acción de Dinamización del ISCIII-MINECO and the Ministry of Health of the Generalitat of Catalunya (ADE 10/00026)
  • Fondazione IRCCS Ca’ Granda ‘5permille’ ‘COVID-19 Biobank’ (RC100017A)
  • Fondazione IRCCS Ca’ Granda ‘Ricerca corrente’, Fondazione Sviluppo Ca’ Granda ‘Liver-BIBLE’ (PR-0391)
  • The European Union (EU) Programme Horizon 2020 (777377)
  • Ricerca Finalizzata Ministero della Salute (RF-2016-02364358)
  • German Federal Ministry of Education and Research (01KI20197)
  • German Research Foundation (DFG) through the Research Training Group
  • Deutsche Forschungsgemeinschaft (437857095, 433116033, 279645989)
  • Novo Nordisk Foundation (NNF17OC0027594, NNF14CC0001)
  • German Federal Ministry of Education and Research (BMBF) within the framework of the Computational Life Sciences (031L0165)
  • Deutsche Forschungsgemeinschaft Cluster of Excellence ‘Precision Medicine in Chronic Inflammation’ (EXC2167)
  • German Federal Ministry of Education and Research (01KI20197)